维昇药业-B(02561)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02561 维昇药业-B

未开盘 06-09 16:08:13

20.200

-0.020

-0.10%

最高20.820	最低20.040	成交量3,300
今开20.040	昨收20.220	日振幅3.86%
总市值23.03亿	流通市值23.03亿	总股本1.14亿
成交额6.71万	换手率0.00%	流通股本1.14亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02561","market":"HK","secType":"STK","nameCN":"维昇药业-B","latestPrice":20.2,"timestamp":1780992493001,"preClose":20.22,"halted":0,"volume":3300,"delay":0,"changeRate":-0.0009891196834816802,"floatShares":113999999,"shares":113999999,"eps":-2.8211758989310014,"marketStatus":"未开盘","change":-0.02,"latestTime":"06-09 16:08:13","open":20.04,"high":20.82,"low":20.04,"amount":67074,"amplitude":0.038576,"askPrice":20.38,"askSize":2000,"bidPrice":20.2,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-2.8361616615646263,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781055000000},"marketStatusCode":0,"adr":0,"listingDate":1742486400000,"exchange":"SEHK","adjPreClose":20.22,"openAndCloseTimeList":[[1780968600000,1780977600000],[1780981200000,1780992000000]],"volumeRatio":0.13382,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02561","defaultTab":"news","newsList":[{"id":"1196239374","title":"维昇药业-B回购0.57万股股份，总额约11.72万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196239374","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196239374?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:37","pubTimestamp":1780915027,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年6月8日公告，基于翌日披露报表显示，公司当日于香港联交所场内回购普通股合计5,700股，占回购前公司已发行股份约0.005%。每股价格介乎港币20.40元至港币20.74元，平均每股购回价为港币20.56元，合计付出约11.72万港元。回购完成后，公司已发行股份数目为113,829,464股，库存股增至97,400股，整体股本总数仍为113,926,864股。公司确认已遵守香港联交所相关上市规则及适用法律法规，并强调所有必要程序和批准均已取得。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B回购0.57万股股份，总额约11.72万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641485193","title":"维升药业-B(02561)6月8日斥资11.72万港元回购5700股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641485193","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641485193?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:33","pubTimestamp":1780914827,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，于2026年6月8日，该公司斥资11.72万港元回购5700股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106076487","title":"维昇药业-B回购8,500股股份，总额约17.51万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106076487","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106076487?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:56","pubTimestamp":1780653368,"startTime":"0","endTime":"0","summary":"维昇药业-B（股票代码：02561）于2026年6月5日公告，公司在香港联交所场内回购8,500股，占当日公司已发行股份（不包括库藏股）约0.007%。每股回购价介乎20.2港元至21港元，涉资约17.51万港元。\n回购完成后，公司已发行股份（不包括库藏股）数目变动为113,835,164股，库藏股数目增至91,700股。购回授权由股东于2025年6月27日批准，授权总数为11,392,686股。公司已根据该授权累计回购91,700股，占授权通过当日已发行股份（不包括库藏股）数目的约0.08049%。\n公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由执行董事卢安邦签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B回购8,500股股份，总额约17.51万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641111143","title":"维升药业-B(02561)6月5日斥资17.51万港元回购8500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641111143","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641111143?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:56","pubTimestamp":1780653368,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，于2026年6月5日斥资17.51万港元回购8500股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165290156","title":"维昇药业-B回购1.61万股股份，总额约33.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165290156","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165290156?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:57","pubTimestamp":1780577845,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年6月4日公告显示，公司当日回购16,100股，占现有已发行股本约0.014%。此次回购最高价格为每股20.88港元，最低价格20.48港元，合计耗资332,476港元。交易完成后，公司已发行股份总数为113,843,664股，库藏股数增至83,200股，合计仍为113,926,864股。该次回购基于2025年6月27日董事会通过的股份回购授权，授权总数为11,392,686股。公司同时确认已遵守上市规则及相关法例。此公告由执行董事卢安邦签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B回购1.61万股股份，总额约33.25万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146143913","title":"维昇药业-B回购3,800股股份，总金额约8.13万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146143913","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146143913?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:51","pubTimestamp":1780491108,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年6月3日发布公告，披露当日通过香港联交所场内回购3,800股普通股，涉及已发行股本约0.003%。本次回购价格介乎每股21.08港元至21.54港元，合计金额为81,320港元。本次回购完成后，公司已发行股份总数维持在113,926,864股不变，其中已发行股份为113,859,764股，库存股份数则增至67,100股。截至公告日，公司已在包括香港联交所等市场合计回购67,100股，占获授权时已发行股本总数约0.0589%。公司确认，本次回购已符合相关法律法规以及香港联交所证券上市规则的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B回购3,800股股份，总金额约8.13万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640047589","title":"维升药业-B(02561)6月3日斥资8.13万港元回购3800股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640047589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640047589?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:49","pubTimestamp":1780490974,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，于2026年6月3日斥资8.13万港元回购3800股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146787920","title":"维昇药业-B：6月2日回购5,000股，耗资约10.87万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146787920","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146787920?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:41","pubTimestamp":1780400468,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年6月2日发布公告，披露于同日通过香港联交所场内回购公司股份5,000股，约占当日回购前公司已发行股本0.004%。本次回购每股价格介乎21.40港元至22.00港元之间，回购均价为21.73港元，合计涉资108,666港元。公司股东会已于2025年6月27日通过回购授权，授权可回购股份总数为11,392,686股，截至本次回购完成，累计已回购股份63,300股，占授权通过当日已发行股本约0.05556%。公司确认本次回购已遵守香港联交所证券上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B：6月2日回购5,000股，耗资约10.87万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640103899","title":"维升药业-B(02561)6月2日耗资约10.87万港元回购5000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640103899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640103899?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:38","pubTimestamp":1780400313,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)公布，2026年6月2日耗资约10.87万港元回购5000股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180944348","title":"维昇药业-B发布5月股份变动月报表，回购49,700股转为库存","url":"https://stock-news.laohu8.com/highlight/detail?id=1180944348","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180944348?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:38","pubTimestamp":1780389522,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年6月2日发布截至2026年5月31日的股份变动月报表。报告显示，公司法定/注册股本维持500,000,000股不变，每股面值0.0001美元，注册股本总额50,000美元，与上月持平。公司在5月内没有新增发行或注销股份，回购活动合计49,700股，回购价格区间介于每股22.86港元至24.41港元，相关股份被持作库存股。公司在公告中披露的股权激励计划当月无新股发行业务，现有激励计划可能发行的最高股份数量为2,399,500股，截至本月未有增发或调拨的新增股份。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640958229","title":"维升药业-B(02561)6月1日斥资18.75万港元回购8600股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640958229","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640958229?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:16","pubTimestamp":1780308988,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，于2026年6月1日，该公司斥资18.75万港元回购8600股股份，每股回购价21.54-22港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170141863","title":"维昇药业-B：6月1日回购8,600股，涉资约18.75万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170141863","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170141863?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:16","pubTimestamp":1780308960,"startTime":"0","endTime":"0","summary":"2026年6月1日，维昇药业-B发布公告，公司当日通过香港联交所场内回购普通股8,600股，占此前已发行股份约0.008%。本次回购每股价格介乎21.54港元至22港元，合计耗资187,516港元。本次交易后，公司已发行股份由113,877,164股降至113,868,564股，库存股份由49,700股增至58,300股。公司购回授权于2025年6月27日获得通过，可回购股份总数为11,392,686股，截至目前已累计回购58,300股。公司确认本次股份回购已获得董事会正式授权，并遵守上市规则与相关法律法规。本公告由执行董事卢安邦签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B：6月1日回购8,600股，涉资约18.75万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138825418","title":"维昇药业-B5月27日回购6,300股股份，耗资约14.65万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138825418","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138825418?lang=zh_cn&edition=full","pubTime":"2026-05-27 17:32","pubTimestamp":1779874327,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年5月27日公告称，公司于香港联交所场内回购6,300股股份，约占相关事件前公司已发行股本113,883,464股的0.006%。本次回购价格介乎每股港币22.72元至23.8元，合计耗资港币146,480元。回购完成后，公司已发行股本变更为113,877,164股，库存股份增加至49,700股，公司已发行股本总数仍为113,926,864股。根据公告，股东大会于2025年6月27日通过购回授权，授权可购回股份最多11,392,686股，截至目前已累计购回49,700股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B5月27日回购6,300股股份，耗资约14.65万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183150723","title":"维昇药业-B 5月26日回购1.02万股，耗资约23.31万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183150723","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183150723?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:56","pubTimestamp":1779793004,"startTime":"0","endTime":"0","summary":"维昇药业于2026年5月26日发布公告，当日于香港联交所场内回购普通股10,200股，约占公司当日现有已发行股本的0.009%。回购价格区间在每股22.66港元至23.48港元之间，合计耗资约23.31万港元。本次回购完成后，公司已发行股份由2026年5月22日的113,893,664股下降至113,883,464股，库存股份增至43,400股。公告显示，维昇药业-B已于2025年6月27日通过购回授权，可回购总数为11,392,686股。公司在公告中确认已就本次回购事宜取得董事会授权，并遵守香港联交所证券上市规则及相关法例。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B 5月26日回购1.02万股，耗资约23.31万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638516555","title":"维升药业-B(02561)5月26日斥资23.31万港元回购1.02万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516555","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638516555?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:54","pubTimestamp":1779792860,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，于2026年5月26日该公司斥资23.31万港元回购1.02万股，回购价格为每股22.66-23.48港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164456621","title":"维昇药业-B回购9,000股股份，合计约21.44万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164456621","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164456621?lang=zh_cn&edition=full","pubTime":"2026-05-22 18:21","pubTimestamp":1779445288,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年5月22日发布翌日披露报表，公告当天在香港联交所场内回购公司股份共9,000股，约占2026年5月20日现有已发行股本0.008%。本次回购每股价格介乎23.48港元至24港元，合计涉资约21.44万港元。本次股份购回完成后，公司已发行股本变动至113,893,664股，库藏股增至33,200股，总已发行股本为113,926,864股。购回授权的决议已于2025年6月27日通过，授权总额为11,392,686股，截至目前公司已根据授权在联交所合共回购33,200股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B回购9,000股股份，合计约21.44万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637313423","title":"维升药业-B(02561)5月22日斥资21.44万港元回购9000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637313423","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637313423?lang=zh_cn&edition=full","pubTime":"2026-05-22 18:20","pubTimestamp":1779445207,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，该公司于2026年5月22日斥资21.44万港元回购9000股股份，每股回购价格为23.48-24港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114136131","title":"维昇药业-B回购8,800股股份，总额约21.48万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114136131","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114136131?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:42","pubTimestamp":1779273750,"startTime":"0","endTime":"0","summary":"维昇药业-B（02561）于2026年5月20日公告披露，当日于香港联交所场内回购8,800股普通股，占公司已发行股本约0.008%。每股回购价格介乎港币23.4元至24.88元，涉资总额约21.48万港元。此次回购完成后，公司已发行股本总数维持113,926,864股，库存股数增至24,200股。\n公司回购授权通过日期为2025年6月27日，可回购股份的总数为11,392,686股。根据公告内容，目前公司已累计回购股份24,200股。公司方面表示，相关回购事项遵守了香港联合交易所有限公司证券上市规则及其他适用法律法规。本公告由公司执行董事卢安邦签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B回购8,800股股份，总额约21.48万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636084699","title":"维升药业-B(02561)5月20日斥资21.48万港元回购8800股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636084699","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636084699?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:41","pubTimestamp":1779273666,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，该公司于2026年5月20日斥资21.48万港元回购8800股股份，每股回购价格为23.4-24.88港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444048.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154448059","title":"维昇药业-B回购6,200股股份，总额约14.96万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154448059","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154448059?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:26","pubTimestamp":1779186373,"startTime":"0","endTime":"0","summary":"2026年5月19日，维昇药业-B 发布翌日披露报表，公告显示公司于香港联交所回购6,200股普通股，占相关股份回购前已发行股本约0.005%。每股购回价格介乎港币23.00元至24.56元，合计耗资约14.96万港元。回购完成后，公司已发行股本由113,917,664股减少至113,911,464股，同时库藏股数量由9,200股增至15,400股。公司回购授权于2025年6月27日经股东决议通过，可回购股份总数为11,392,686股。公告同时披露，公司已遵守香港联合交易所相关上市规则及法规的规定。本公告由执行董事卢安邦签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B回购6,200股股份，总额约14.96万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.visenpharma.com","stockEarnings":[{"period":"1week","weight":-0.0818},{"period":"1month","weight":-0.1939},{"period":"3month","weight":-0.3688},{"period":"6month","weight":-0.4648},{"period":"1year","weight":-0.5661},{"period":"ytd","weight":-0.3841}],"compareEarnings":[{"period":"1week","weight":-0.0565},{"period":"1month","weight":-0.0693},{"period":"3month","weight":-0.0515},{"period":"6month","weight":-0.0378},{"period":"1year","weight":0.0159},{"period":"ytd","weight":-0.0415}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"维昇药业是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。该公司的主要在研产品包括隆培促生长素、那韦培肽和帕罗培特立帕肽。隆培促生長素用于治疗3至17岁儿童生长激素缺乏症患者。那韦培肽是一款用于治疗2至10岁软骨发育不全儿童患者的疾病修复疗法。帕罗培特立帕肽是一款用于治疗成人甲状旁腺功能减退症的治疗方法。该公司处于研发后期、产品接近商业化。","exchange":"SEHK","name":"维昇药业-B","nameEN":"VISEN PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维昇药业-B(02561)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维昇药业-B(02561)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维昇药业-B,02561,维昇药业-B股票,维昇药业-B股票老虎,维昇药业-B股票老虎国际,维昇药业-B行情,维昇药业-B股票行情,维昇药业-B股价,维昇药业-B股市,维昇药业-B股票价格,维昇药业-B股票交易,维昇药业-B股票购买,维昇药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维昇药业-B(02561)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维昇药业-B(02561)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}